ASHP statement on the pharmacy and therapeutics committee and the formulary system

Daniel T. Abazia, Philip Anderson, Lilian M. Azzopardi, Kenneth R. Baker, James L. Besier, J. Lyle Bootman, David G. Bowyer, Maureen Brady, Margaret Chrymko, Joseph W. Cranston, Steven Dzierba, Michael Gaunt, Pamela C. Hagan, Raymond W. Hammond, Eric T. Hola, Patricia Kienle, Katharine Kiser, Thomas L. Kurt, Timothy R. Lanese, Rosario J. LazzaroMelvin E. Liter, Patrick M. Malone, Candis M. Morello, Richard O'Brocta, Folakemi T. Odedina, James A. Ponto, Curt W. Quap, Mike Rouse, Marissa Schlaifer, Shelley Hoppe Schliesser, Michele F. Shepherd, Jonalan Smith, Allen J. Vaida, William E. Wade, Tom W. Woller, John L. Woon

Research output: Contribution to journalArticlepeer-review

30 Scopus citations
Original languageEnglish (US)
Pages (from-to)2384-2386
Number of pages3
JournalAmerican Journal of Health-System Pharmacy
Volume65
Issue number24
DOIs
StatePublished - Dec 15 2008

Keywords

  • American Society of Health-System Pharmacists
  • Formulary system
  • Guidelines
  • Organizations
  • Pharmacy and therapeutics committee
  • Pharmacy, institutional, hospital

ASJC Scopus subject areas

  • Pharmacy
  • Pharmacology
  • Health Policy

Cite this